Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Active versus Passive Immunity

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

γδ T cells at the interface of innate and adaptive immunity in cancer.

Journal for immunotherapy of cancer·2026

Same author

A Case for Anti-IgE Vaccination.

Allergy·2026

Same author

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity.

Vaccines·2025

Same author

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.

Viruses·2025

Same author

The impact of viral evolution on vaccine development for SARS-CoV-2.

Current opinion in immunology·2025

Same author

A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralising antibodies against porcine epidemic diarrhoea viruses (PEDV).

Veterinary research·2025

Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026

Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026

Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026

Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026

Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026

Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 14, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Active immunotherapy for chronic diseases.

Martin F Bachmann¹, Piers Whitehead

¹University Hospital Zurich, Dermatology, Gloriastr 31, 8091 Zurich, Switzerland. martin.bachmann@me.com

|February 19, 2013

Summary

This summary is machine-generated.

Active immunization offers a novel approach for chronic diseases, overcoming limitations of monoclonal antibodies like immunogenicity and high costs. This strategy contrasts with passive immunization, highlighting distinct therapeutic advantages.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Related Experiment Videos

Last Updated: May 14, 2026

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Area of Science:

Immunology and Therapeutics
Chronic Disease Management

Background:

Chronic, non-communicable diseases are leading causes of mortality and morbidity globally.
Monoclonal antibodies (mAbs) are established treatments but face challenges in chronic settings.
Key limitations of mAbs include anti-antibody generation and high manufacturing costs.

Purpose of the Study:

To introduce and discuss a novel therapeutic strategy for chronic diseases.
To compare active immunization with passive immunization (mAbs) for chronic disease treatment.
To elucidate the advantages and disadvantages of each treatment modality.

Main Methods:

Conceptual discussion and comparative analysis of active versus passive immunization.
Review of existing literature on monoclonal antibody therapy for chronic conditions.
Exploration of active immunization principles in the context of non-communicable diseases.

Main Results:

Active immunization presents a potential alternative to address mAb shortcomings.
Active immunization may offer improved long-term efficacy and reduced treatment burden.
Comparison highlights distinct benefits and drawbacks for both active and passive approaches.

Conclusions:

Active immunization represents a promising avenue for chronic disease management.
This approach could mitigate issues associated with monoclonal antibody therapy.
Further research is warranted to fully explore the potential of active immunization strategies.